INTRODUCTION
Inflammatory bowel diseases (IBDs) such as Crohn's disease (CD) and ulcerative colitis (UC) are two chronic and relapsing pathologies of the small and large intestine that affect millions of individuals worldwide (1). Extensive genome-wide association studies (GWAS) revealed 200 IBD-associated genetic loci, and recent high-resolution fine mapping identified statistically convincing causal variants (2) . Studies in mice have provided insight into the cellular composition of the intestinal mucosa, including mononuclear phagocytes (3), adaptive and innate lymphoid cells (ILCs) (4) , intercellular communication circuits maintaining gut homeostasis (5) , and the impact of microbiota (6) . Animal IBD models have better defined genetic factors causing, contributing to, or preventing intestinal inflammation (7) . One such module consists of the cytokine interleukin-10 (IL-10), associated signaling components, such as Stat3 (8, 9) , and IL-10 receptor (IL-10R) (9, 10) .
Most of the intestinal macrophages reside in the connective tissue or lamina propria, underlying the monolayer of epithelial cells (ECs). As nonmigratory cells, they do not translocate to draining lymph nodes (LNs) and display limited or no potential to "prime" naive T cells (10) . In adult mice, most lamina propria macrophages are continuously replenished by Ly6C hi blood monocytes (11) . Monocyte-derived cells replace an embryonically derived population in the gut shortly after birth (12) (13) (14) . As opposed to many other tissue macrophages that self-renew in their entirety throughout adult life (15) , adult intestinal macrophages comprise subsets with distinct half-lives (10) . Constant replacement of short-lived gut macrophages necessitates ongoing adaption of monocyte precursors to the dynamic local gut environment, including exposure to microbial stimuli (16) . IL-10, provided by regulatory T cells (17) , is a critical factor ensuring colon homeostasis and preventing the emergence of proinflammatory monocyte-derived cells. Specifically, colonic macrophages unable to sense IL-10 due to Il-10ra deficiency exhibit unrestrained responses in patients (12, 13) . Moreover, mice that also harboring IL-10Ra-deficient macrophages develop severe early onset colitis (14) and, hence, provide a valuable model for mechanistic studies of the human disorder caused by the Il-10ra loss-of-function mutation.
IL-10R-deficient macrophages display a proinflammatory expression signature, including up-regulation of IL-23 (14) , a cytokine composed of two subunits: p19, which is unique to IL-23, and p40, which is shared with IL-12 (18) . IL-23 was shown to contribute to colitis development in several mouse models. After Helicobacter hepaticus infection of lymphopenic Rag2 −/− mice, antibody-mediated neutralization of p19 or p40, but not p35 (the second IL-12 subunit), ameliorated disease (19) , mice are protected from T cell transfer-induced colitis (19) . Moreover, after a combination of H. hepaticus infection and IL-10R blockade, wild-type (WT) and Il12a −/− mice succumb to disease, whereas Il12b −/− mice are spared (20) . The underlying mechanism by which IL-23 drives inflammation may involve interferon--secreting T helper 1 (T H 1) cells and reduced IL-17 levels, although differentiation of T H 17 cells was unaltered in the absence of IL-23 (19) . In support of IL-23 acting on T cells, adoptive transfers of IL-23R-deficient T cells into immunodeficient mice caused less severe colitis than WT T cell engraftment (21) . Several cell types were suggested as the source of IL-23, including monocytes, Cx3cr1 + macrophages, and CD103 + CD11b
+ dendritic cells, although their respective contributions might differ in the small and large intestines (22) (23) (24) (25) .
T cell responses to IL-23 include the production of IL-22, a cytokine acting on ECs, which, in the context of colitis, is widely considered anti-inflammatory. Thus, IL-22 therapy by gene transfer or IL-22 production by neutrophils was shown to ameliorate colitis (26) . Likewise, IL-22-deficient mice displayed increased gut inflammation, both in the dextran sodium sulfate (DSS) and the T cell transfer colitis model (27) . In contrast, in dermal inflammatory diseases such as psoriasis, IL-22 was shown to play a detrimental role (28) . Proinflammatory activities of IL-22 in the gut were reported for an innatedriven colitis model based on the injection of anti-CD40 antibody, which stimulated myeloid cells (29) and caused dysbiosis favoring pathogen colonization potentially due to IL-22-induced antimicrobial peptide (AMP) production (29) . Collectively, IL-22 is widely considered a beneficial agent in gut inflammation and may be involved in wound healing and bacterial protection (30) (31) (32) . Accordingly, IL-22 therapy has been suggested as a possible treatment for patients with IBD (28), although the potential exists for deleterious outcomes associated with chronic IL-22 stimulation of gut ECs.
Here, we investigated macrophage-driven colitis, as manifested in children and mice harboring IL-10R deficiencies (12, 13, 33) . Specifically, we define causative cell responses and reveal the critical role of the IL-23/IL-22 pathway in this IBD pathology. We report that proinflammatory macrophages produce IL-23, which, in turn, recruits T H 17 cells and induces secretion of IL-22. Colonic ECs respond to IL-22 exposure by expression of AMPs and neutrophil chemoattractants that appear to be critical for colitis development.
RESULTS

IL-10Ra-deficient macrophages confer spontaneous colitis involving the IL-23/IL-22 axis
In mice and humans, intestinal macrophages require IL-10 sensing to maintain gut homeostasis (12) (13) (14) . Accordingly, Cx3cr1 cre :Il10ra fl/fl mice harboring IL-10Ra-deficient macrophages develop spontaneous colitis manifested in IBD hallmarks, including tissue remodeling and immune cell infiltrates in the colon, but not the ileum (14) .
Intestinal macrophages extracted from colonic lamina propria of 6-to 7-week-old precolitic Cx3cr1 cre :Il10ra fl/fl mice displayed a proinflammatory gene expression signature (Fig. 1, A and B, and fig S1) . Mutant macrophages exhibit elevated expression of cytokine and chemokine genes, including Il23a, Il12b, and Ccl5; genes encoding activation markers such as trem1; and inflammatory molecules like nos2 and saa3. In total, 310 genes were significantly down-regulated, and 355 genes were significantly up-regulated in mutant cells, as compared with controls (fold change, >2; adjusted P < 0.05).
IL-23R was identified by GWAS as an IBD susceptibility gene (34) , and IL-23-deficient mice are resistant to colitis induction in different IBD mouse models (19, 20, 35) . IL-10ra-deficient macrophages expressed high levels of Il23a, as revealed by RNA sequencing (RNA-seq) (Fig. 1B) and confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) conducted on sorted colonic macrophages (Fig. 1C) . Antibiotic treatment upon weaning abolished the proinflammatory signature of IL-10Ra-deficient colonic macrophages ( fig. S1B ) and IL-23 up-regulation (Fig. 1C) , establishing microbiotaderived signals as macrophage activation stimuli in this model. IL-23 is known to induce IL-22 expression by T H 17 cells and type 3 innate lymphoid cells (ILC3s) (36, 37) . Accordingly, Il22 mRNA levels were elevated in the tissue of mice harboring IL-10Ra-deficient macrophages in a microbiota-dependent manner (Fig. 1C) . In addition, and in line with possible involvement of T H 17 cells in this colitis model, IL-17 transcript levels were significantly up-regulated in whole-tissue extracts of colitic mice (Fig. 1D) (Fig. 1, G and H) . ILC3s extracted from colitic mice also expressed elevated levels of Cxcr6, a chemokine receptor critical for the localization and IL-22 production in the small intestine (Fig. 1H) Fig. 2D ). RNA-seq analysis revealed significant transcriptomic changes of colonic ECs at 14 dpt, which increased at 60 dpt, with 316 and 834 differentially expressed genes, respectively (Fig. 2E) . In contrast to the colonic ECs, ileal ECs showed minimal changes at both time points, although they had been isolated from the same animal ( fig. S2B ). Differentially expressed genes of colonic ECs at early and late time points comprised a prominent signature of IL-22-induced genes (4), including AMPs, CXC chemokines, and members of the calcium binding S100 protein family (S100a8 and S100a9) that encode calprotectin (Fig. 2F) . These chemokines and S100 were absent from ileal EC transcriptomes (Fig. 2F) . The two subunits comprising the IL-22 receptor, Il10rb and Il22ra, were expressed by both ileal and colonic EC under steadystate and inflammatory conditions ( fig. S2D ), indicating the ability of ECs to sense IL-22 in both ileum and colon under steady-state conditions. Expression of the IL-10-specific receptor subunit il10ra was below background levels. Robust AMP and chemokine up-regulation was not only restricted to colitic BM chimeras but also observed in Cx3cr1 cre :Il10ra fl/fl mice, which displayed the up-regulation of Reg3b, Reg3g, Cxcl1, and Cxcl5, already at 6 to 7 weeks of age when signs of colitis were mild, as compared with co-housed Il10ra fl/fl littermate controls ( Fig. 2G and fig. S2F ). In conclusion, before overt signs of intestinal 
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Mutant macrophage production of IL-23 drives colitis in Cx3cr1
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Relative mRNA levels signature, including expression of the aforementioned proinflammatory factors (Fig. 3 , A to C). Thus, Il10ra/Il23 double-deficient cells displayed only seven differentially expressed genes compared with Cx3cr1 gfp control macrophages (Fig. 3C) , and Reg3b expression in colonic whole-tissue RNA extracts of indicated mouse strains. Data were collected from two independent experiments, n ≥ 3 in each group. All mice were age-matched; each dot represents one mouse. n.s., non significant, P > 0.05; *P ≤ 0.05.
and histopathology analysis of co-housed age-matched littermates (Fig. 3, D (43) , which is widely considered to be beneficial (26, 27) but can be harmful under certain circumstances (29) . Given the epithelial IL-22 response to IL-10Ra-deficient macrophages (Fig. 2F) (Fig. 4D) . In contrast and supporting the notion that their induction is a secondary effect potentially requiring the EC response, Ccl5 transcripts were not elevated in macrophages (Fig. 4D ). In addition, levels of il17a transcripts were increased in colonic tissues of Cx3cr1 −/− mice showed increased numbers of IL-17-producing T cells relative to littermate controls (Fig. 4E) . Collectively, these data suggest that, in our model, IL-22 is a required factor for colitis initiation, and its induction is the critical colitogenic response to IL-23 produced by IL-10R-deficient proinflammatory macrophages.
Unexpectedly, WT mice that received Cx3cr1 (Fig. 5A) . qRT-PCR analysis of colonic tissue of colitic BM chimeras showed elevated levels not only of transcripts for the neutrophil recruiting chemokines Cxcl1 and Cxcl5 but also Il22 mRNA (Fig. 5B) ] chimeras 3 weeks after BM transplantation (Fig. 5D) . T H 17 cell numbers were significantly higher in Cx3cr1 cre :Il10ra fl/fl BM recipients (Fig. 5D) , and sorted T H 17 cells from these colitic chimeras exhibited elevated Il22 transcription (Fig. 5E) ] BM chimeras exhibited reduced colitis progression (Fig. 5F ) and low Il22 and Cxcl5 whole-tissue mRNA levels. This result excludes the possibility of IL-22 production by graft-derived cells, supporting the notion of a radio-resistant cell as the exclusive IL-22 source. Collectively, these data suggest that the critical colitogenic cellular source of IL-22 in the Cx3cr1 (Fig. 4C ). Cxcl1 and Cxcl5 were induced in colonic epithelium but not expressed by ileal ECs (Fig. 2F) . In contrast, although induced in the inflamed colon, AMPs were constitutively expressed in ileal epithelium. This suggested that neutrophil attraction, rather than AMP induction, might be critical for the IL-22-driven pathology. In line with this notion, flow cytometry analysis revealed prominent neutrophil infiltrates in the colon of Cx3cr1 fl/fl mice displayed elevated reactive oxygen species production as compared with blood neutrophils of the same animals (Fig. 6C) .
To formally establish the link between IL-22-expressing CD4 + T cells and the neutrophil accumulation, we tested the impact of T cell ablation on neutrophil recruitment (Fig. 6D) . Using an antibody regimen, CD4 + T cells were efficiently depleted from mesenteric LNs, whereas CD8 + T cells remained unaffected (Fig. 6E) + T cells showed significant reduction of neutrophil recruitment (Fig. 6F) . Histological analysis confirmed neutrophil infiltrates in [Cx3cr1 cre :Il10ra fl/fl > WT] mice and the associated loss of colon tissue architecture, which was, as determined by E-cadherin and collagen staining, prevented by the CD4 + T cell depletion (Fig. 6G) . Moreover, reduced neutrophil infiltration correlated with lower Il22, Cxcl1, and Cxcl5 mRNA expression in BM chimeras depleted of CD4 + T cells (Fig. 6H ). As we found CD4 + ILC3s, another prominent IL-22 source associated with Citrobacter rodentium infections (46) , to be radiosensitive, these data support the notion that the cellular sources of procolitic IL-22 in our model are likely T H 17 cells (Fig. 1E) . The depletion experiment places CD4 + T cells and IL-22 upstream of neutrophil recruitment in the cascade of colitis progression. Collectively, our observations point to IL-22 as a proinflammatory factor that is likely secreted by T H 17 cells and induces EC expression of Cxcl1 and Cxcl5, whereby promoting neutrophil recruitment to the intestinal lamina propria.
Ablation of neutrophil infiltrates ameliorates colitis
As neutrophil recruitment appeared to be a hallmark of macrophageinduced colitis, we next tested the contribution of these cells to tissue pathology. Neutrophil extracellular traps (NETs) were shown to promote inflammation in atherosclerosis and mediate tissue damage created by neutrophils in pulmonary infection (47, 48) . However, histological analysis of colitic BM chimeras revealed the absence of NET formation in colonic tissue ( fig. S6A) fig. S6 , B and C). Although we observed a reduction in levels of the neutrophil activation marker CD63 after NEI administration ( fig. S6C ), the treatment had no effect on neutrophil accumulation and tissue Nos2 levels ( fig. S6, D and E) . Last, we ablated neutrophils using the anti-Ly6G antibody (Fig. 7A) . Flow cytometry analysis confirmed the depletion of neutrophils from the colon of the antibody-treated [Cx3cr1 cre :Il10ra fl/fl > WT] BM chimeras (Fig. 7B) , as did histological analysis (Fig. 7C) . The latter revealed significantly reduced tissue damage in the colons of neutrophil-depleted animals, as indicated by the absence of villi hypertrophy and loss of cell polarity that was observed in colon areas with high neutrophil infiltrates of the immunoglobulin G (IgG)-treated control mice (Fig. 7C) . Whole-tissue RNA analysis by qRT-PCR revealed decreased levels of Nos2 expression in neutrophil-depleted BM chimeras (Fig. 7D) . Of note, macrophages and EC also produced Nos2 under inflammatory conditions according to our RNA-seq data (Figs. 1, A and B, and 2F) ; the fact that neutrophil depletion was sufficient to reduce tissue Nos2 levels suggests that either these cells are the main source of this enzyme or macrophage Nos2 expression is downstream of neutrophil recruitment.
To test for such a potential effect of the neutrophil ablation on macrophage transcriptomes, we performed RNA-seq analysis on these cells isolated from anti-Ly6G and control IgG-treated [Cx3cr1 BM chimeras (Figs. 1, A and B, and 2F). Neutrophil ablation did not significantly impair macrophage expression of proinflammatory factors, such as Nos2, Ccl5, and Saa3 (Fig. 7E and fig.  S7A ), but either the absence of neutrophils or the ensuing improved tissue context did affect the global macrophage transcriptomes ( fig. S7B ). Collectively, these data establish that the neutrophil recruitment induced by epithelial response to IL-22 has a major contribution to tissue damage in IL-10R-deficient macrophage-driven colitis ( fig. S8 ).
DISCUSSION
Here, we focused on understanding the critical steps in the induction and progression of macrophage-driven colitis, as manifested in children and mice harboring IL-10R deficiencies (12, 13 
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Relative mRNA levels Using a conditional double mutagenesis strategy, we established macrophage-derived IL-23 as the critical driver of the disease. Macrophages from Cx3cr1 cre :Il10ra fl/fl :Il23a fl/fl mice that lack the ability to produce IL-23, in addition to the IL-10R deficiency, no longer develop a proinflammatory gene signature. Our results corroborate and strengthen the key role of IL-23 in colonic inflammation that has been suggested earlier for the other experimental models (19, 25, 35) . Moreover, we establish a critical hierarchy of proinflammatory factors, with macrophagederived IL-23 at the apex of the cascade. Of note, IL-23 expression in macrophages is tightly controlled, including dedicated posttranscriptional circuits (49, 50) that have been linked to IL-10 (51). Collectively, this highlights IL-23 as a prime target for colitis therapy, as also supported by the clinical success of Ustekinumab, a monoclonal antibody that specifically blocks the IL-23 subunit p40 (52, 53).
We found macrophage-derived IL-23 to induce colonic T H 17 cells and ILC3 to secrete IL-22, as also suggested in other colitis models (25) . However, unlike earlier studies that involved DSS or T cell transfers into lymphopenic mice (27) in psoriasis (36), IL-22 production is deleterious in our IBD model. Rather, colitis driven by IL-10R-deficient macrophages in animals that harbor normal T cell compartments, and hence probably also IL-10R-deficient pediatric patients, more closely resembles the pathology induced by anti-CD40 treatment (29) . The latter model lacks conventional T cells and therefore implies ILC3s as the IL-22 source, corroborating an earlier study (54) . In contrast, in our model that retains both conventional and unconventional T cells, we assigned IL-22 production to T H 17 cells. Shouval and colleagues (55) reported enhanced T H 17 responses in patients with IL-10R deficiency and infantile-onset IBD, the close human counterpart of our model (12, 13) . The pathogenicity of T H 17 cells was also highlighted in a recent study that reported a direct link between H. hepaticus colonization and the generation of these cells (56) . H. hepaticus infection of IL-10-deficient mice induced inflammatory T H 17 cells in the colon, but not in the ileum, in line with the notion that IBD pathology is restricted to the large intestine in both IL-10-deficient and Cx3cr1 cre :Il10ra fl/fl mice. Collectively, our study and the one by Littman and colleagues (56) highlight the importance to investigate key drivers of IBD pathology also in models that retain conventional T cells, in addition to lymphopenic or immunodeficient mice.
A proinflammatory role of IL-22 has been identified in skin pathologies such as acanthosis and psoriasis (36) and was suggested to be related to keratinocyte hyperplasia. In the context of the gut, Salmonella enterica ser. Typhimurium was shown to benefit from IL-22 induction because EC-derived AMPs provided a competitive colonization advantage for the pathogen (57) . As to the mechanism of how IL-22 promotes inflammation, the data point to a critical role of EC-derived neutrophil chemoattractants in our model. Specifically, T H 17-derived IL-22 induces ECs to express the chemokines Cxcl1 and Cxcl5 alongside AMPs (58) . The observed tight link between neutrophil infiltrates and gut pathology in the Cx3cr1 cre :Il10ra fl/fl mouse colitis model suggests that these factors are a major components in its pathological cascade, as recently proposed for the anti-CD40 colitis model (29) .
The Cx3cr1 cre :Il10ra fl/fl mouse provides a colitis model mimicking infantile-onset IBD (12, 13) . A major difference between the murine model and human disorder is that, in the patients, all cells harbor the IL-10R deficiency, whereas in the mouse model, the deletion is restricted. Other cells that are impaired in IL-10 sensing, such as T regulatory cells, could hence contribute to pathology. We show that macrophage-derived IL-23 drives the pathology and establishes critical roles of the T cells, ECs, and neutrophils. Future studies will be needed to address the molecular nature and source of the stimuli that establish the full proinflammatory signature of the IL-10R-deficient macrophages, beyond IL-23 expression. Our data reveal distinct inducer and effector modules in macrophage-driven colitis, as manifested in children and mice harboring IL-10R deficiencies. Neutralization of both modules in patients that globally lack the critical signal transducer Stat3, due to loss-of-function mutations affecting the open reading frame, does not result in colitis but in other morbidities (59) . Our studies predict that variants that affect Stat3 expression in myeloid cell only might confer IBD risk. Several of the STAT3 single nucleotide polymorphisms (SNPs) reported to be associated with IBDs are located within regulatory elements (11) . Future studies using targeted CRISPR-Cas9 mutagenesis of these regulatory elements will be required to test our assumption. However, collectively our findings support the validity of conditional mu tagenesis in mouse models to define critical cell type-specific activities that promote IBD pathology.
Together, this study provides mechanistic insight into the cascade of intercellular communication events triggered by IL-10R-deficient macrophages in the colon. IL-23 produced by the mutant cells emerged as a critical trigger of T H 17 cells that secrete IL-22 and thereby initiate an epithelial cell response that results in deleterious recruitment of neutrophils. Our findings might have direct implications for pediatric patients harboring IL-10R deficiencies (60) and add to our general understanding of cell type-specific contributions to IBD pathology. (63) . Only male mice were used. BM chimeras were generated by engraftment of recipient mice that were irradiated the day before with a single dose of 950 cGy using a XRAD 320 machine (Precision X-Ray Inc.). All animals were on C57BL/6 background and bred at the Weizmann Animal Facility. Sentinels in our facility were typed H. hepaticus positive. Whenever possible, age-matched co-housed males were used for experiments. Animals were maintained under specific pathogen-free conditions and handled according to protocols approved by the Weizmann Institute Animal Care Committee as per international guidelines.
MATERIALS AND METHODS
Mice
Cell isolation, flow cytometry analysis, and sorting of intestinal macrophages and intestinal ECs
For the isolation of colonic ECs, extra-intestinal fat tissue and blood vessels were carefully removed, and colons were then flushed of their luminal content with cold phosphate-buffered saline (PBS), opened longitudinally, and cut into 0.5-cm pieces. Colon pieces were incubated in RPMI 1640 medium supplemented with 2 mM EDTA, 10% fetal bovine serum (FBS), 1% penicillin-streptomycin, and 1% sodium pyruvate for 40 min at 37°C shaking at 250 rpm.
For the isolation of colonic lamina propria cells, EC and mucus were removed by 40-min incubation with Hanks' balanced salt solution (without Ca2 + and Mg2 + ) containing 5% FBS, 2 mM EDTA, and dithiothreitol [0.15 mg/ml (1 mM); Sigma-Aldrich] at 37°C shaking at 250 rpm. Colon pieces were then digested in PBS +/+ containing 5% FBS, collagenase VIII (1 mg/ml; Sigma-Aldrich), and deoxyribonuclease I (0.1 mg/ml; Roche) for 40 min at 37°C shaking at 250 rpm. The digested cell suspension was then washed with PBS and passed sequentially through 100-and 40-mm cell strainers. The following antibodies were used to stain the surface markers of the cells: CD45 (30-F11), Ly-6C (HK1.4), CD11b (M1/70), CD11c (HL3), Ly6G (1A8), CD64 (X54-5/7.1) from BioLegend, Bio-gems, or eBioscience, and CD103 (M290) from BD Biosciences. Cells were analyzed with the LSRFortessa flow cytometer (BD Biosciences) or sorted using a FACSAria Table 1 for primers used for qPCR.
RNA-seq and analysis
For EC mRNA sequencing core facilities total RNA was extracted from 0.1 to 1 × 10 6 sorted cells with the RNeasy Micro Kit (Qiagen). One-hundred nanograms of total RNA was processed using the TruSeq Stranded Total RNA HTSample Prep Kit (with Ribo-Zero Gold) of Illumina (RS-122-2303). Libraries were evaluated by Qubit and TapeStation. Sequencing libraries were constructed with barcodes to allow multiplexing of 24 samples ran on three lanes. A total of 20 million single-end 50-base pair reads were sequenced per sample on a Illumina HiSeq 2500 high output mode instrument. Macrophage mRNA was sequenced using MARSeq, as previously described (62) . Briefly, 10 4 to 10 5 cells from each population were sorted into 50 l of lysis/binding buffer (Life Technologies). mRNA was captured with 15 l of DynaBeads oligo(dT) (Life Technologies), washed, and eluted at 85°C with 6 l of 10 mM tris-Cl (pH 7.5). A total of 5 million reads were sequenced per library. In both cases, gene expression levels were calculated using the HOMER software package (analyzeRepeats.pl rna mm9 -d <tagDir> -count exons -condenseGenes -strand + -raw) (63) . Normalization and differential expression analysis were perfomed using the DESeq2 R package.
Histopathological analysis
Analysis was performed as previously described with minor adjustments (14) . Briefly, colon was fixed in 2% paraformaldehyde solution overnight at 4°C, then embedded in paraffin, and sectioned and stained with hematoxylin and eosin. Tissues were examined in a blinded manner by a pathologist. Three segments of the colon (proximal colon, medial colon, and distal colon/rectum) were given a score between 0 and 4, and the average of these scores provided a total colonic disease score.
Immunohistochemistry
For T cell and ILC3 staining, tissues were fixed in 2% paraformaldehyde at 4°C and stained for CD3 (SP7, Abcam) and GFP (polyclonal IgG ab6658, Abcam) overnight at 4°C. Alexa Fluor 488-conjugated donkey antigoat and Cy3-conjugated donkey antirabbit (Jackson Immuno Research) secondary antibodies were added for 1 hour. Nuclei were stained with Hoechst. Images were acquired using a Nikon Eclipse Ti inverted spinning disc confocal microscope with 20× air objectives, with Andor iQ software, and analyzed with Volocity 6.1.1 software (Improvision Ltd.).
For neutrophil and tissue damage staining after dewaxing and rehydrating, the formalin-fixed, paraffin-embedded gut sections were incubated in Target Retrieval solution (pH 9.0) (S236884-2, Agilent Technologies LDA UK Limited) at 97°C for 45 min. Sections were incubated with primary antibodies mouse anti-E-Cadherin antibody (1:500 dilution; 610181, BD Biosciences) and rabbit polyclonal to collagen IV (1:500 dilution; ab6586, Abcam PLC), followed by Alexa Fluor 488-conjugated donkey antimouse [1:200 dilution; A21202, Thermo Fisher Scientific (Life Technologies)], Alexa Fluor 568-conjugated donkey antirabbit, Alexa Fluor 647-conjugated anti-Ly6G, and DAPI (4′,6-diamidino-2-phenylindole). Then, tissues were mounted with ProLong Gold Antifade Mountant [P36934, Thermo Fisher Scientific (Life Technologies)] and examined with confocal microscopy. Image analysis was performed using ImageJ.
Antibiotic treatment
For antibiotic treatment, mice were given a combination of vancomycin (0.5 g/l), ampicillin (1 g/l), kanamycin (1 g/l), and metronidazole (1 g/l) in their drinking water upon weaning and continuously until they were euthanized. All antibiotics were obtained from Sigma-Aldrich.
In vivo cell depletion and NEI treatment
For CD4 depletion, mice were injected intravenously with 100 g of the anti-CD4 antibody (clone GK1.5, BioXcell) or isotype control (clone LTF2, BioXcell). For neutrophil depletion, mice were injected intraperitoneally with 120 g of anti-Ly6g antibody (clone 1A8, BioXcell) or rat serum IgG control (Sigma-Aldrich). NEI was purchased from Axon Medchem and injected intraperitoneally at 2.5 g/g every 3 days.
Quantification and statistical analysis
In all experiments, data are presented as means if not stated otherwise; each dot represents one mouse. Statistical tests were selected on the basis of appropriate assumptions with respect to data distribution and variance characteristics. Student's t test (two-tailed) was used for the statistical analysis of differences between two groups. One-way analysis of variance (ANOVA) followed by Bonferroni correction was used for the statistical analysis of differences between three or more groups. Statistical significance was defined as P < 0.05. Sample sizes were chosen according to the standard guidelines. The number of animals is indicated as "n". Of note, sizes of the tested animal groups were also dictated by availability of the transgenic strains and litter sizes, allowing littermate controls. Pre-established exclusion criteria are based on Institutional Animal Care and Use Committee guidelines. Animals of the same age, sex, and genetic background were randomly assigned to treatment groups. The investigator was not blind to the mouse group allocation. Tested samples were blindly assayed.
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